Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...
Brokerages report wide AI use, but agents say the payoff isn’t consistently converting to more closings. A 2026 snaps...
A federal court in Massachusetts struck down a $100,000 fee on new H-1B petitions, a move that could boost demand fro...
Elon Musk’s net worth surged above $1.1 trillion, driven by SpaceX and Tesla gains, rewriting the hierarchy at the ve...
Real estate teams are pivoting from high-volume dialing to intent driven AI follow-up, showing faster responses and s...
A leading market technician says the baton in leadership is shifting from mega-cap tech to cyclical sectors, with thr...
A Wall Street Journal probe alleges polymarket used staged bets to fuel viral growth, prompting questions about trans...
Rivian has made bold moves in a high-stakes market. With shares drifting down this year, this guide weighs the case f...